Roche says it plans to offer the drug to patients in India at a much discounted price. Photo: Reuters

Roche's oral therapy 'Evrysdi' to provide cost-effective alternative against fatal genetic disorder SMA in India

Jul 29, 2021

Until now, SMA in India was curable only with the two most expensive and imported gene therapies -- Spinraza and Zolgensma -- from Biogen-Ionis and Novartis. Treatment for SMA costs over Rs 16-18 crore in India

The AZD1222 vaccine is pending a US Food and Drug Administration (USFDA) application

COVID-19 vaccine: AstraZeneca to apply for approval in US later this year

Jul 29, 2021

As part of second-quarter financial results released on Thursday, the approvals timetable indicates a USFDA approval application for COVID-19 Vaccine AstraZeneca SARS-CoV-2 (US) later in the year

Earlier on Friday, Bharat Biotech said it had terminated the MoU to sell Covaxin to Brazil's Precisa Medicamentos and Envixia Pharmaceuticals LLC

Brazil shelves import authorisation of Covaxin days after scrapping EUA request

Jul 29, 2021

According to a statement issued by Brazil's National Health Surveillance Agency, Anvisa, its Collegiate Board on Tuesday decided to suspend the authorisation for import and distribution of Covaxin in the country after Bharat Biotech informed the South American government about the termination of its pact with its Brazilian partners

 Demand for its raw materials used in COVID-19 vaccines and therapies is likely to sustain in the year (Source: Reuters)

Thermo Fisher slashes 2021 COVID-19 test sales forecast by $900 mn

Jul 29, 2021

The company benefited from strong demand during the pandemic, but rising vaccination has hit demand for these tests and other test makers have also warned of a slump

For Pfizer, antibody levels reduced from a median of 7506 Units per millilitre (U/mL) at 2141 days, to 3320 U/mL at 70 or more days

Pfizer, AstraZeneca vaccine antibody may wane after 2-3 months: Lancet study

Jul 27, 2021

The researchers from University College London (UCL) in the UK noted that if the antibody levels carry on dropping at this rate, there are concerns that the protective effects of the vaccines may also begin to wear off, particularly against new variants

Shares of GlaxoSmithKline Pharmaceuticals Ltd closed at Rs 1,726.20 per scrip on BSE

Drug firm GSK Pharma's Q1 net profit rises 9% to Rs 121 crore

Jul 27, 2021

The company had posted a net profit of Rs 110.83 crore for the corresponding period of the previous fiscal, GlaxoSmithKline Pharmaceuticals said in a regulatory filing

The trial is being conducted by categorising children as per their age wherein 175 children of each age group have been included

Results of Covaxin trials on children expected by Sept: AIIMS chief

Jul 24, 2021

"The vaccines for children should come out now because trials in India are already there in the vaccines which are available in India, the Bharat Biotech trial is in the final phase by September we will have the data," Dr Guleria told ANI

Moderna's COVID-19 vaccine was granted emergency use authorisation by India's drug regulator last month

India may not get Moderna COVID-19 vaccine till 2022

Jul 24, 2021

The Centre is still holding discussions with the US-based pharma company regarding the production of its mRNA technology-based COVID-19 vaccine as part of the country's vaccination programme

Bharat Biotech has terminated a memorandum of understanding to sell its COVID-19 vaccine Covaxin to Brazil's Precisa Medicamentos (Source:Reuters)

Bharat Biotech terminates MoU to sell Covaxin to Brazil's Precisa Medicamentos

Jul 23, 2021

Bharat's statement said it will continue to work with Brazilian healthcare regulator Anvisa to obtain all required approvals for the use of Covaxin in the country

At full operational capacity, the annual COVID-19 vaccine production will target 100 million finished doses annually

Biovac-Pfizer collaboration a breakthrough for Covid in Africa: Cyril Ramaphosa

Jul 23, 2021

Biovac has been appointed to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within Africa, making it the first company on the continent to produce an mRNA-based vaccine

Serum Institute of India writes to Health Minister

Serum writes to Health Minister to propose reforms in drug regulatory system

Jul 22, 2021

Prakash Kumar Singh, Director, Government and Regulatory Affairs at Pune-based SII, in a letter, referred to a gazette notification by the Union Health Ministry on May 18, 2020